In one study including four female patients with postsurgical hypoparathyroidism, s.c. injection of 100 μg GIP markedly reduced plasma CTX levels despite very low or undetectable PTH concentrations, indicating that its antiresorptive effect does not rely on PTH-mediated pathways. The gene discussed is PTH; the disease is hypoparathyroidism.